Registration
COVINGTON & BURLING LLP for SUCAMPO PHARMACEUTICALS INC.
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Foreign government regulatory treatment of drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN D SMITH New | Office of the Counsel to the President/White House (1997-98) ; ; Special Assistant, Department of Labor (OSEC) (1996) ; ; Special Assistant, Department of Labor (OCIA) (1995) |
| JOHN VERONEAU New | Deputy U.S. Trade Representative ; ; Gen. Counsel & Assistant USTR for Congressional Affairs ; ; Ass't Secretary & DAS, Legislative Affairs, Dept. of Defense ; ; Chief of Staff, U.S. Senator Susan Collins ; ; Legislative Director, U.S. Senator William Frist ; ; Leg. Ass't, Leg. Counsel, Leg. Dir., Sen. William Cohen |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| SUCAMPO MANUFACTURING & RESEARCH AG | Switzerland | Switzerland | 100.0% | — |
| SUCAMPO PHARMA EUROPE, LTD. | United Kingdom | United Kingdom | 100.0% | — |
| SUCAMPO AG | Switzerland | Switzerland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.